Lucent Diagnostics, a division of Quanterix Corporation (NASDAQ: QTRX), has launched LucentAD Complete, an innovative multi-marker blood test aimed at enhancing Alzheimer’s Disease (AD) detection across a wider patient population.…
Healthcare Workforce Logistics (HWL), a leader in healthcare workforce management solutions, has been recognized as a recommended Managed Service Program (MSP) provider in Staffing Industry Analysts’ (SIA) recent report on…
Exact Sciences Corp. (NASDAQ: EXAS), a leader in cancer screening and diagnostics, has announced that it will present modeling data assessing the benefits and burdens of established colorectal cancer (CRC)…
Jupiter Endovascular, Inc., a medical technology startup focused on pioneering endovascular procedures with its Endoportal Control™ platform, has announced the successful treatment of the first U.S. patient in the SPIRARE…
Modalis Therapeutics Corporation (Tokyo Stock Exchange: 4883, CEO: Haru Morita) has announced that the U.S. Food and Drug Administration (FDA) has granted Orphan Drug Designation (ODD) to MDL-101, a novel…
Agomab Therapeutics NV has announced an $89 million (€82.1 million) Series D financing round, featuring contributions from new investors Sanofi and Invus, alongside support from existing investors. Agomab Therapeutics plans…
Upfront Healthcare’s collaboration with Prisma Health, which has successfully engaged nearly one million patients, is featured in the latest issue of The Healthcare Administration Leadership & Management (HALM) Journal. Published…
Simulations Plus, Inc. (Nasdaq: SLP), a top provider of biosimulation and performance solutions for the biopharma industry, has announced its financial results for the fourth quarter and fiscal year 2024,…
Align Technology, Inc. (Nasdaq: ALGN), a leading global medical device company known for its Invisalign® clear aligners, iTero™ intraoral scanners, and exocad™ CAD/CAM software for restorative dentistry, has announced the…
AMRA Medical, in collaboration with the University of Oslo, has published a study examining the effects of antidepressants (ADs), particularly serotonin-selective reuptake inhibitors (SSRIs) and tricyclic antidepressants (TCAs), on muscle…
Hesperos, Inc., a leader in human biology modeling for drug development through its Human-on-a-Chip® technology, is excited to announce the appointment of Lawrence (Larry) Florin as Chief Executive Officer. With…
GE HealthCare (Nasdaq: GEHC) has introduced CareIntellect for Oncology, a new cloud-based application that consolidates multi-modal patient data from various systems into a single, streamlined view. Utilizing generative AI, the…